Sadaf Medical Conducting a breast exam training for JBCP

MammaCare and Sadaf Medical Bring Safe and Effective Breast Exams to Jordanian Women

MammaCare, a global leader in breast exam training and certification, and Sadaf Medical of Jordan, a leading distributor of medical equipment and training resources, have established an exclusive partnership to assure that all Jordanian women have access to safe and effective breast exams by highly skilled hands.

The partnership between MammaCare and Sadaf Medical will revolutionize breast exams for Jordanian women, by assuring that the commonly performed clinical breast exam can detect and/or confirm the earliest signs of breast cancer without increasing false positive alarms.

Since 1974, MammaCare has delivered state-of-the-art technology and training programs for healthcare providers. The scientifically validated training methods enable medical professionals to perform safe and effective breast exams, improving the chances of detecting abnormalities at an early stage. 

MammaCare’s web-based training platform is the only known technology that teaches, measures, and verifies breast exam skills. Clinicians are required to meet standards of sensitivity, specificity and thoroughness in order to pass each breast exam. 

"We are thrilled to embark on this partnership with Sadaf Medical Supplies," said Zachary DeLand, MammaCare’s COO. "Together, we are committed to ensuring that Jordanian women receive the highest standard of breast exams. Clinicians must be able to accurately and reliably confirm or dispel what their patients report."

"We believe that by combining MammaCare's top-tier clinical training with our distribution network, we can make a significant impact on women's health in Jordan," stated Mr. Mutaz Abu Zaitoon, Managing Director of Sadaf Medical. "Our joint efforts will undoubtedly result in more accurate and effective breast examinations, leading to better healthcare outcomes."

For more information about MammaCare and Sadaf Medical, please visit and

Clinical Breast Exam + US – More Accurate than Mammogram

physical breast exam and ultrasound

When a woman or clinician feels or sees an unusual change in the breast, the woman is typically referred for a mammogram (conventional or 3-D) also referred to as a digital breast tomosynthesis (DBT) scan.

It is expected that the radiologist who views the mammogram scans will be able to identify the location of the palpable lump in order to reject it as being a benign observation, or something that requires further investigation. 

Unfortunately, mammograms can miss a substantial portion of breast cancers that are present.1

Automated breast ultrasound (ABUS) and/or magnetic resonance (MRI) may be used following a mammogram to determine if a biopsy is required. 

Stand-Alone Mammogram Less Accurate than Physical Breast Exam with Targeted Ultrasound

Recent evidence from high income national health care programs finds that a physical exam is essential for early diagnoses.2 The latest evidence comes from Holland. Dr. Linda Appleman’s team investigated what happens when a lump is immediately followed up by targeted ultrasound rather than a mammogram.3

From September 2017 to June 2019, 1,961 women in Holland reported feeling a lump and enrolled into Appleman’s study. Each woman received a targeted ultrasound (US) to determine if the lump she felt was a harmless water-filled cyst or a solid tumor that required biopsy. With ultrasound (US) as the primary imaging tool, 81% of women received normal (benign) results, and 10% of women received confirmation of a malignant tumor (US sensitivity, 98.5% [95% CI: 96, 100]; US specificity, 90.8% [95% CI: 89, 92]). DBT was used after an ultrasound reported negative lump finds to validate ultrasound’s accuracy in order to determine if US could be used as a stand-alone breast imaging modality for assessing lump finds from a physical breast exam.

Dr. Appleman concluded that “[ultrasound] was accurate as a stand-alone breast imaging modality in the assessment of focal breast complaints.”

Michelle Annette Wintjen, FNP Certified as a MammaCare Clinical Breast Examiner

Stony Brook Southampton Meeting House

On March 3, 2023, Michelle Annette Wintjen, a licensed Family Nurse Practitioner, became certified as a MammaCare Clinical Breast Examiner for the Stony Brook Southampton Hospital, Meeting House Lane Medical Practice in New York

Studies of breast cancer symptoms in national healthcare programs confirm that a lump is the earliest and most common sign of breast cancer. It is also known that in between screenings, self-detected breast lumps reveal cancers missed by mammograms. Examinations by practitioners with documeted palpation skills are trained to thoroughly evaluate patient-detected lesions. Certified clinical breast examiners with verified skills are a first line of care reccomended for women with elevated risk risk of breast cancer.

The MammaCare Method of breast examination is the result of decades of research supported in part by the National Cancer Institute and National Science Foundation. It is the recognized standard for practice and training for clinical breast exams skills, competencies and certification. The skill-based program involves guided practice and performance measurement on tactually accurate breast models and on live surrogates. 

Graduates like Mrs.Wintjen earned certification as a MammaCare Clinical Breast Examiner via live, guided, online practice and training in which clinicians meet rigorous performance standards of sensitivity, specificity and exam thoroughness. 

"The MammaCare method is systematic and organized. Obtaining MammaCare training and certification has equipped me with the skills and confidence I need to provide the best possible clinical breast exam to my patients. I look forward to putting it into practice."

- Michelle Wintjen, FNP, CBE-MC


The MammaCare Foundation is a 501(c)(3) non-profit foundation dedicated to training every hand that examines a woman, including her own. The MammaCare Method is the recognized standard for performing and teaching clinical and personal breast examination. MammaCare provides clinical certification services and high-fidelity simulation-based training.

Breast Exam Competence, Finally a Breakthrough

GAINESVILLE, Fla., Jan 17 , 2023  -- The earliest and most frequent sign of breast cancer is a lump or lesion, often self-detected.1, 2, 3 There was however, no known way to measure or confirm whether a patient’s health provider possessed the clinical skills required to palpate and confirm the presence of the self-reported breast lesion or lump. 4, 5, 6 Without verifiable clinical skills the exam is often deferred or conducted haphazardly.

In response, MammaCare® created the first digital technology that automatically calculates, analyzes and corrects the breast exam skills of healthcare providers, nursing and medical students before they begin examining patients. The Clinical Breast Exam Simulator-Trainer instantly measures and documents core competency levels: sensitivity (detecting small suspicious lesions), specificity (false positive detections), thoroughness (percent of tissue examined and missed), and reports the search pattern(s) performed.

In practice, a clinician or student simply logs on to the web portal and begins examining a series of cloud-connected breast models containing replicas of excised breast cancers. The online training program guides the examiner's fingers as they learn to positively identify sub-centimeter breast lumps while learning to avoid false positive detections.

Multiple CBE Simulator Attempts

When performance does not meet built-in standards, the system automatically presents feedback about the deficiency and requests the examiner to try again. The additional practice enables virtually all users to pass each module by the second or third attempt. Data from the first 3000 participants in colleges of nursing, medicine and breast cancer early detection programs verify significant improvement in each of the core breast exam competencies noted above. 

Mark Kane Goldstein, Ph.D. MammaCare Foundation Sr. Scientist reported: "A few hours of practice, using any computer connected to the Trainer will measurably improve a provider's ability to confirm and report suspicious breast lesions for further diagnostic workup." He added: "Strong evidence now indicates that merging the human tactile sensory system with advanced engineering technology supports the early detection of breast cancer." 7, 8

The MammaCare Foundation

(352) 375.0607 MammaCare Lab

Google Scholar

VA Mini Residencies Advance Clinical Breast Exam Skills

The Journal of Women's Health published a landmark report on the 10 year mini-residency training program provided to thousands of VA Primary Care Providers (PCPs). MammaCare provided the hands-on Clinical Breast Exam CBE Simulator-Trainer  for the VA mini-residency program. The PCPs retained and used the performance skills acquired at the mini-residences reporting significantly greater comfort/confidence levels in performing clinical breast exams.

Improving Public Health

The MammaCare CBE Simulator-Trainer was developed and validated with the support of the National Science Foundation and was adopted for clinical training in the Woman Veterans Health Program as well as in CDC's sponsored National Breast and Cervical Early Detection and Prevention Programs (NBCCEDP).  The skill-based technology has begun training advanced clinicial students in U.S. colleges of nursing and medicine to advance clinical breast exam skills. 

Mini-Residencies Improve Care for Women Veterans: A Decade of Re-Educating Veterans HealthAdministration Primary Care Providers

Linda Baier Manwell, MS, Melissa McNeil, MD, MPH, Megan R. Gerber, MD, MPH, Samina Iqbal, MD, Sarina Schrager, MD, MS, Catherine Staropoli, MD, Roger Brown, PhD, Laure Veet, MD, Sally Haskell, MD, MS, Patricia Hayes, PhD, and Molly Carnes, MD, MS

Background: Many primary care providers (PCPs) in the Veterans Health Administration need updated clinical training in women’s health. The objective was to design, implement, and evaluate a training program to increase participants’ comfort with and provision of care to women Veterans, and foster practice changes in women’s health care at their local institutions. 

Methods: The Women’s Health Mini-Residency was developed as a multi-day training program, based on principles of adult learning, wherein knowledge gleaned through didactic presentations was solidified during small-group case study discussions and further enhanced by hands-on training and creation of a facility-specific action plan to improve women Veterans’ care. Pre, post, and 6-month surveys assessed attendees’ comfort with and provision of care to women. The 6-month survey also queried changes in practice, promulgation of program content, and action plan progress 

Results: From 2008 to 2019, 2912 PCPs attended 26 programs. A total of 2423 (83.2%) completed pretraining and 2324 (79.3%) completed post-training surveys. The 6-month survey was sent to the 645 attendees from the first 14 programs; 297 (46.1%) responded. Comparison of pre-post responses indicated significant gains in comfort managing all 19 content areas. Six-month data showed some degradation, but comfort remained significantly improved from baseline. At 6 months, participants also reported increases in providing care to women, including performing more breast and pelvic examinations, dissemination of program content to colleagues, and progress on action plans

Keywords: Veterans health; clinical competence; continuing; curriculum; education; primary health care; women's health.

Global Breast Cancer: The Way Forward

Global Epidemic - Late-Stage Breast Cancer Morbidity and Mortality: Breast cancer is the most frequent, and fatal malignancy in women, worldwide.1 In 2020 alone, 2.3 million women were newly diagnosed, and 685,000 died from breast cancer. Moreover, 7.8 million women live with breast cancer, making it the most prevalent of all cancers according to the world health organization's Global Cancer Observatory (GCO).2 Breast cancer also exceeds all cancers in lost disability-adjusted life years (DALYs) with nearly 20 million years of health lost.3 While the unmet need appears daunting, evidence confirms that early detection programs can markedly downstage the disease for a majority of women, significantly extending their lives and health.20, 21 

Global Breast Exam Competencies: The earliest and most frequent symptom of breast cancer is a lump detected by hand, often at a later stage than necessary due to unskilled performance of the exam.4, 5, 6 Laboratory studies of breast exam accuracy and competencies were conducted beginning in 1980 with the support of the National Cancer Institute (NCI).7, 8, 9, 10, 11, 12, 13 Subsequent research advanced the methods and standards for training and practice with accurately simulated breast models containing subcentimeter lesions engineered to mimic the tactile properties and variations of breasts. Guided palpation on the breast models enabled women and their providers to acquire uniform tactile skills for reliable detection and reporting of small, pea sized suspicious lesions (0.3cm-0.5cm) while reducing false positives and false negatives.14, 15, 16, 17, 18

Global Technology Transforms Touch: Training technology developed with the support of the US National Science Foundation (NSF) led to a computer-guided, self-administered system that directly measures and calibrates the hands of users (trainees) who learn and practice essential tactile skills. The trainer generates a real-time, online digital profile that quantifies performance and validates progress. The system is now training hands throught US and international academic and clinicial instutions to perform competent and thorough breast exams. Trainees’ performance and achievement levels are quantified and automatically reported to instructors and clinical supervisors.

Table 1. presents data analytics from > 5000 students and clinicians.

Global Approach - Literally in Our Hands: A Nobel Prize was awarded this year for recognizing the extraordinary sensitivity and accuracy of human touch receptors.19   The collective evidence now indicates that human biology and technology are now ready to assist in the early detection of breast cancer. The approach for downstaging breast cancer globally is literally in our hands: We know that a small palpable breast lump is the earliest sign of breast cancer, and that early detection and treatment can provide a normal lifespan for millions of women, and finally, we have a proven technology to uniformly train and verify essential skills in hands, everywhere across the connected globe. This powerful yet simple universal training and monitoring technology can provide the essential tactile breast exam skills for millions of women and their caregivers at little cost to bring down the massive global burden of advanced breast cancer.22

MammaCare © all rights reserved

    1. Harbeck, N., Penault-Llorca, F., Cortes, J. et al. Breast cancer. Nat Rev Dis Primers 5, 66 (2019).
    2. Sung, Hyuna, et al. "Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries." CA: a cancer journal for clinicians 71.3 (2021): 209-249.
    3. Ji, Peng, et al. "The burden and trends of breast cancer from 1990 to 2017 at the global, regional, and national levels: results from the global burden of disease study 2017." Frontiers in oncology 10 (2020): 650.
    4. Koo, Minjoung Monica, et al. "Presenting symptoms of cancer and stage at diagnosis: evidence from a cross-sectional, population-based study." The Lancet Oncology 21.1 (2020): 73-79.
    5. Larsen, Marthe, et al. "Self-reported symptoms among participants in a population-based screening program." The Breast 54 (2020): 56-61.
    6. McDonald, Sharon, Debbie Saslow, and Marianne H. Alciati. "Performance and reporting of clinical breast examination: a review of the literature." CA: a cancer journal for clinicians 54.6 (2004): 345-361.
    7. Hall, Deborah C., et al. "Improved detection of human breast lesions following experimental training." Cancer 46.2 (1980): 408-414. 
    8. Stefanek, Michael E., Patti Wilcox, and Anne Marie Huelskamp. "Breast self-examination proficiency and training effects: women at increased risk of breast cancer." Cancer Epidemiology and Prevention Biomarkers 1.7 (1992): 591-596.
    9. Sauter, Edward R., and Mary B. Daly, eds. Breast cancer risk reduction and early detection. Springer Science & Business Media, 2010.
    10. BLOOM, HS, EL CRISWELL, and HS PENNYPACKER. "Major stimulus dimensions determining detection of simulated breast lesions."
    11. Pinto, Bernardine M. "Training and maintenance of breast self-examination skills." American journal of preventive medicine 9.6 (1993): 353-358.
    12. Adams, C. K., Hall, D. C., Pennypacker, H. S., Goldstein, M. K., Hench, L. L., Madden, M. C., ... & Catania, A. C. (1976). Lump detection in simulated human breasts. Perception & Psychophysics, 20(3), 163-167.
    13. Fletcher, Suzanne W., et al. "How best to teach women breast self-examination: A randomized controlled trial." Annals of Internal Medicine 112.10 (1990): 772-779.
    14. Barton, Mary B., Russell Harris, and Suzanne W. Fletcher. "Does this patient have breast cancer?: The screening clinical breast examination: should it be done? How?." Jama 282.13 (1999): 1270-1280.
    15. Vetto, John T., et al. "Structured clinical breast examination (CBE) training results in objective improvement in CBE skills." Journal of Cancer Education 17.3 (2002): 124-127.
    16. Saslow, Debbie, et al. "Clinical breast examination: practical recommendations for optimizing performance and reporting." CA: a cancer journal for clinicians 54.6 (2004): 327-344.
    17. Jacob, Teresa C., et al. "A comparison of breast self-examination and clinical examination." Journal of the National Medical Association   86.1 (1994): 40.
    18. 18. Benincasa, Theresa A., et al. "Results of an office‐based training program in clinical breast examination for primary care physicians." Journal of Cancer Education1 (1996): 25-31.
    20. Duggan, Catherine, et al. "National health system characteristics, breast cancer stage at diagnosis, and breast cancer mortality: a population-based analysis." The Lancet Oncology 22.11 (2021): 1632-1642.
    21. Bain, Carolyn, et al. "Model for early detection of breast cancer in low-resource areas: the experience in Peru." Journal of global oncology   (2018): 1-7.
    22.  pe=2&statistic=5&prevalence=1&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17&group_cancer=1&include_ 

Trained Hands Can Reduce Advanced Breast Cancer Worldwide

GAINESVILLE, Fla., Oct. 15, 2020 -- More than 600,000 women die of advanced breast cancer annually. (1) There is a safe, universally obtainable method to reduce this terrible toll according to MammaCare Foundation scientist Mark Kane Goldstein, Ph.D.: "By producing more skilled hands everywhere," he reported.

Scientific and clinical evidence indicate that properly trained hands can detect small, suspicious, breast tumors before they advance to late, untreatable malignancies. (2) Although breast exams are performed widely, they are not performed well without training and practice. Recognizing the work of renowned inventor Louis Braille who calibrated fingers to read tiny raised dots, MammaCare scientists applied Braille's principles to breast exams by calibrating the sense of touch to the detection of sub-centimeter tumors in complex breast tissues.


With the support of the National Science Foundation, MammaCare created a breast exam training platform and program that works anywhere while connected to Google Chrome's internet browser. Exam performance is converted into a data stream that can be reviewed by instructors who are given remote access.

The portable devices interact with and guide practitioners and students performance while monitoring and shaping their clinical exam skills on connected, tactually accurate, breast models until they reliably detect all suspicious, pea-sized (<0.5cm) tumors present. False positives are reduced by learning to feel and confirm the difference between tumors and normal, lumpy breast tissues also present in the models.

MammaCare deployed the first version of the technology for the Women Veterans Health Program and is now equipping U.S. colleges of nursing and medicine, as well as  Congressionally-sponsored National Breast and Cervical Cancer Early Detection Programs (NBCCEDP).(3) (4) (5)

The worldwide need for skilled hands is demonstrated in MalaysiaAfricaUSIndiaQatar/ PakistanCanada, Goldstein reported, adding that "reproducible, inexpensive technology now allows us to reach out within and across continents to calibrate and validate the essential exam skills of local nurses and practitioners for early detection, helping thereby to bring down the massive global burden of advanced, late stage breast cancer." (6)(7)(8)(9)(10)(11)

Module 1
Module 1
Module 2
Module 2











(3) Women Veterans Health (US -Women Veterans)


(5)Google Scholar MammaCare

(6) (Malaysia)

(7) (Iran)

(8) (India)

(9) (Africa)

(10) (Qatar)/(Pakistan)

(11) (Canada)


Mark Kane Goldstein, Ph.D.

Mary Ann Mehn, Ph.D.



Intelligent Machine Calibrates and Corrects Clinical Breast Exams

Although a common presenting symptom of breast cancer is a lump, untrained practitioners are not likely to confirm its presence without essential skills.


Intelligent Machine Calibrates and Corrects Clinical Breast Exams

To our knowledge this is the first transformation of a clinical skill into a live digital stream that measures, corrects and validates competence.

Millions of physical examinations of the breast (CBEs) are performed on women each year to confirm or dispel the presence of a self-reported tumor. Until now it was impossible to measure the accuracy and calibrate the skills of this commonly performed exam. Development of an intelligent, highly sensitive sensory technology that converts the exam into a digital data stream enables providers to measure, analyze and correct performance.

The portable, hands-on teacher plugs into any computer that connects to the internet, calculates practitioners' true and false positive detections, missed tumors and exam thoroughness. It reports their progress in real time and continues practice until built-in standards are met.

More than a decade of research and technology development was supported by NCI, NSF, Capgemini, Qlik, and Women Veteran Health Program. It is now training and verifying the breast exam skills of nurses physicians midwives and breast radiologic technicians.

chart, line chart



Follow the Evidence

Faculty of Nursing professor Dr. Anne Kearney was in the final minutes of supervising an exam when she decided to check her email.Upon reading a message from a friend who sent her a link to a Globe and Mail story, she broke out into a happy dance — at the back of the classroom, where her students wouldn’t notice.

It was news she’d been waiting to hear for more than 15 years: Women don’t need rigid breast screening schedulestated the headline.

Shared decision-making

The story reported on a long-awaited report by the Canadian Task Force on Preventive Health Care about the use of mammography as a population-based screening tool for women aged 50-74.

Population-based means that screening is recommended for all women in a targeted age group, not just for women at higher risk.

The big news contained in the report? Clinicians must now engage women in shared decision-making about whether to have mammography screening or not, which acknowledges there is “very low certainty evidence” of effectiveness.

In fact, the task force concluded there is no evidence of mortality reduction overall and good evidence of harm, including over-diagnosis (which results in unnecessary treatment), along with false positives and resulting biopsies.

“I no longer thought the breast screening program was heading in a way that was based on evidence.”— Dr. Anne Kearney

The report’s authors wrote that screening of women aged 50-74 is conditional on primary care providers discussing potential benefits and harms so that women can make an informed decision about whether the benefits outweigh the risks.

That might not sound earth-shattering, but according to Dr. Kearney, who has followed the debate and reviewed the evidence related to the risks of mammography screening for more than 20 years, it’s a significant change.

“There must have been a lively and animated conversation,” she said, noting that the report was almost a full year late. “If something is strongly recommended they would say, ‘We strongly recommend.’ But the screening recommendation is conditional, or weak, which is very important.”

Dr. Kearney described the four main risks associated with mammography screening in a recent Gazette op-ed.

Education lead for breast-screening program

Until the task force published its report in early December, population-based mammography screening had been endorsed by clinicians and stakeholders across the country since the late 1980s.

Dr. Kearney was part of a small group to establish Newfoundland and Labrador’s breast screening program, which launched in 1996. As lead for public and professional education with the program, it was her job to review the most current research on population-based screening.

It was then she began to notice the conflicting reports about effectiveness of mammography screening, the usefulness of clinical breast examination and that breast self-examination was being increasingly questioned by researchers and physicians.

“It was a very confusing time for me,” she said. “I no longer thought the breast screening program was heading in a way that was based on evidence.”

Doctoral work

Dr. Kearney began her PhD in 1998, focusing on breast self-examination, because of the conflicting information she was finding. Her work also included a review of mammography screening effectiveness. She completed her PhD in 2004.

And over the past number of years she has presented and written extensively about breast-screening evidence in an effort to change policy.

“We have it all wrong in my opinion: We should not screen all women of a targeted age with mammography; primary care providers should examine women’s breasts; and women should examine their own breasts.”

Dr. Kearney’s mother died of breast cancer at age 53, so she’s quick to point out that she doesn’t “take this issue lightly.”

Along the way there have been small triumphs, such as winning best poster at the  2016 Applied Research in Cancer Control conference held in Toronto, where she was called “brave” for presenting her work at at a time when not all stakeholders appreciated it.

But with the task force now qualifying their recommendation about mammography screening, Dr. Kearney says she feels vindicated.

There’s still much more work to do, she says, including ensuring that women are informed of potential harms and benefits of mammography screening and changing policy to support clinical breast examination and breast self-examination.

The next task force recommendations, she hopes, will unequivocally recommend against population-based mammography screening for women of any age.

“It is a cost-intensive initiative that causes significant harm without evidence of mortality reduction.”

Marcia Porter is a communications advisor with the Faculty of Nursing. She can be reached at

Georgia DPH Deploys New Breast Exam Training Technology to Improve Accuracy

First in Nation to Upgrade Breast Exam Standards

Women in Georgia will benefit from the breast exam training program developed by MammaCare scientists with the support of the National Science Foundation. The team of scientists identified the specific breast exam skills required for early detection of small suspicious tumors while reducing false positives. They produced a hands-on, computer-guided simulator technology that validates the performance of these critical skills. In cooperation with the Georgia Department of Public Health Breast and Cervical Cancer Program (BCCP), the MammaCare system will train nurses in each of Georgia’s 159 counties. The training technology is in use by the Women Veterans Health Program and by US colleges of nursing and medicine. Georgia’s DPH is the first BCCP to deploy the training system statewide.

Although nurses and physicians routinely examine women’s breasts for suspicious lesions or tumors, performance and results vary widely. Mary Ann Mehn, Ph.D., MammaCare’s Director of Education, said that Georgia DPH staff public health nurses are now being trained and certified to deploy the system throughout Georgia’s BCCP. Mark Kane Goldstein, Ph.D., MammaCare Senior Scientist explained: “The MammaCare Clinical Breast Exam Simulator-Trainer standardizes critical performance skills with a series of “intelligent” breast models that measure exam accuracy and provide corrective feedback in real time.” “If performance on any one of the breast exam modules does not meet built-in standards of sensitivity, specificity, and thoroughness, the program requires the user to repeat the module before moving on to the next one,” Goldstein added.

MammaCare, the recognized standard for clinical and personal breast exams, began in 1974 as a National Cancer Institute project to determine the smallest palpable breast tumor that is reliably detectable by hand. MammaCare training technology and certification courses are available at

The MammaCare Clinical Breast Exam Simulator-Trainer standardizes critical performance skills with a series of ‘intelligent’ breast models that measure exam accuracy and provide corrective feedback in real time.


Mary Ann Mehn, Ph.D.,

Mark Kane Goldstein, Ph.D.

Cell: 352.256.4573

Office: 352.375.0607

CBE Simulator-Trainer Video